Arymo ER is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Egalet Us Inc.. The primary component is Morphine Sulfate.
Product ID | 69344-211_a9e64fc1-683a-483e-8754-b759844174bb |
NDC | 69344-211 |
Product Type | Human Prescription Drug |
Proprietary Name | Arymo ER |
Generic Name | Morphine Sulfate |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2017-02-01 |
Marketing Category | NDA / NDA |
Application Number | NDA208603 |
Labeler Name | Egalet US Inc. |
Substance Name | MORPHINE SULFATE |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2017-02-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208603 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-02-01 |
Ingredient | Strength |
---|---|
MORPHINE SULFATE | 30 mg/1 |
SPL SET ID: | e60552c9-06ce-4790-95e7-aadd4df12b2a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
69344-211 | Arymo ER | Arymo ER |
69344-111 | Arymo ER | Arymo ER |
69344-311 | Arymo ER | Arymo ER |
0023-6011 | Kadian | morphine sulfate |
0023-6012 | Kadian | morphine sulfate |
0023-6013 | Kadian | morphine sulfate |
0023-6014 | Kadian | morphine sulfate |
0023-6015 | Kadian | morphine sulfate |
0023-6016 | Kadian | morphine sulfate |
0023-6017 | Kadian | morphine sulfate |
0023-6018 | Kadian | morphine sulfate |
0023-6019 | Kadian | morphine sulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ARYMO 86270024 5191560 Live/Registered |
Egalet Ltd. 2014-05-02 |